Show simple item record

More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition

dc.contributor.authorJohnson, MB
dc.contributor.authorHattersley, AT
dc.contributor.authorPatel, KA
dc.date.accessioned2021-03-09T09:34:25Z
dc.date.issued2021-01-07
dc.identifier.citationVol. 384, pp. 93 - 94en_GB
dc.identifier.doi10.1056/NEJMc2032806
dc.identifier.urihttp://hdl.handle.net/10871/125070
dc.language.isoenen_GB
dc.publisherMassachusetts Medical Societyen_GB
dc.rights.embargoreasonUnder embargo until 7 July 2021 in compliance with publisher policyen_GB
dc.rights© 2021 Massachusetts Medical Society.en_GB
dc.titleMore on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibitionen_GB
dc.typeArticleen_GB
dc.date.available2021-03-09T09:34:25Z
dc.descriptionThis is the final version. Available from the Massachusetts Medical Society via the DOI in this recorden_GB
dc.identifier.eissn1533-4406
dc.identifier.journalNew England Journal of Medicineen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2021
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2021-01-07
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-03-09T09:32:43Z
refterms.versionFCDVoR
refterms.dateFOA2021-07-06T23:00:00Z
refterms.panelAen_GB


Files in this item

Name:
nejmc2032806.pdf
Size:
303.6Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record